FindTrial
Sign In

Dexmedetomidine as an additive to bupivacaine for pain relief in children

Dexmedetomidine as an adjuvant to bupivacaine in caudal analgesia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046248
Enrollment
60
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Bupivacaine with Dexmedetomidine: Bupivacaine(0.25%) 1ml/kg + dexmedetomidine 1mcg/kg in 1 ml as dosage for caudal block assessment of pain relief and hemodynamics in post-operative p

Sponsors

Government Of Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I ,II and III Patients scheduled for Infraumbilical surgeries Elective surgeries/ Emergency surgeries Consent from Legally Authorized Representative

Exclusion criteria

Exclusion criteria: ASA IV and V Parents refusing to give consent Patients having pre-existing cardiac, neurological and respiratory diseases Patients having coagulopathy Patients with congenital spine anomaly Local infection/inflammation

Design outcomes

Primary

MeasureTime frame
To study postoperative pain relief in both groups. To compare duration of analgesia in both groups. Timepoint: 24 hours post operative—

Secondary

MeasureTime frame
To compare postoperative complication in both groups. Intraoperative hemodynamic parameters in both groupsTimepoint: 24 hours post operative—

Countries

India

Contacts

Public ContactDr Tejal Mehta

B.J. medical college and civil hospital, Ahmedabad

gjmehta17@yahoo.com9825881489

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026